Advertisement

Topics

Regeneron reports $388 million in second-quarter net income

11:00 EDT 24 Aug 2017 | Healio

Regeneron reported a GAAP net income of $388 million, or $3.66 per basic share and $3.34 per diluted share, in the second quarter of 2017 compared with a GAAP net income of $196 million, or $1.88 per basic share and $1.69 per diluted share, in 2016’s second quarter.Total revenues increased to $1.470 billion from $1.213 billion in the second quarter of 2016, which includes net product sales of $924 million compared with $834 million in 2016, according to a press release.

Original Article: Regeneron reports $388 million in second-quarter net income

NEXT ARTICLE

More From BioPortfolio on "Regeneron reports $388 million in second-quarter net income"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...